Company Overview
- Headquarters
- 611 Gateway Blvd. Suite 400, South San Francisco CA
- Website
- harpoontx.com
- Phone
- (650) 443-7400
- Employees
- 55
- Founded in
- 2015
- Industry
- Materials/Manufacturing
- NAICS Code
-
NAICS Code 541714 CompaniesNAICS Code 54171 CompaniesNAICS Code 54 CompaniesNAICS Code 5417 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 87 CompaniesSIC Code 873 Companies
Financials & Stats
Revenue
$21B
Total Funding Amount
$131M
Who is Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage company based in South San Francisco, California. With 55 employees, the company focuses on developing innovative therapies in the field of immuno-oncology. Harpoon Therapeutics specializes in developing a novel class of T cell engagers, engineered proteins designed to activate a patient's own immune system to target and destroy cancer cells. Their proprietary TriTAC® platform is used to create these T cell engagers, initially targeting solid tumors and hematologic malignancies. The company has also developed two additional proprietary platforms: ProTriTAC™, a prodrug concept applied to their TriTAC platform for targeted tumor activation, and extended release TriTAC-XR, designed to minimize the risk of cytokine release syndrome. For more information about Harpoon Therapeutics and their innovative cancer treatments, please visit www.harpoontx.com.
Company Leadership
Harpoon Therapeutics Tech Stack
Companies Similar to Harpoon Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Harpoon Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 21M | 38 | Irvine, CA | 2007 | |
| 21M | 244 | Salem, NH | 1987 | |
| 21M | 6 | Manchester, CT | 2002 | |
| 20M | 91 | Chicago, IL | 1997 | |
| 20M | 106 | Suwanee, GA | 1952 |